Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988687 · ClinicalTrials.gov registry record
Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD
A clinical trial, sponsored by Garcia, Jose M., MD, PhD.
- Completed
- Registry status
- 7
- Enrollment target
NCT02988687: Completed study, sponsored by Garcia, Jose M., MD, PhD.
NCT02988687 is a clinical trial that has completed, run by Garcia, Jose M., MD, PhD. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02988687 has completed, sponsored by Garcia, Jose M., MD, PhD.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This PILOT, NON-INTERVENTIONAL STUDY will follow patients about to start rhGH for a period of six months and collect valuable pilot data to evaluate feasibility of a larger study and treatment tolerability and compliance. The effect of rhGH on cognitive function, depression, fatigue, sleep quality, and QOL will also be collected. This exploratory study will also provide important information about recruitment and AGHD screening procedures in military settings.
Primary Outcome
Quality of Life Assessment for GHD in Adults questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-10 |
What the finished NCT02988687 record still lists
NCT02988687 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02988687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02988687 about?
NCT02988687 is a clinical study titled "Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD". This PILOT, NON-INTERVENTIONAL STUDY will follow patients about to start rhGH for a period of six months and collect valuable pilot data to evaluate feasibility of a larger study and treatment tolerability and compliance. The effect of rhGH on cognitive function, depression, fatigue, sleep quality, ...
What is the current status of trial NCT02988687?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2016-11. Estimated completion is 2022-10.
Who is sponsoring clinical trial NCT02988687?
This trial is sponsored by Garcia, Jose M., MD, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia